ESC 24: Hot Line & Late-breaking Science Video Collection
Published: 15 August 2024
-
Views:
2589
-
Likes:
7
-
Views:
2589
-
Likes:
7
-
Up Next -
13m 47sPart 5 | Session 2 3 Trials That Will Change My Practice With Dr Michelle Kittleson
-
6m 55sPart 6 | Session 1 New Guidelines for the Management of Atrial Fibrillation -
6m 13sPart 6 | Session 2 New Guidelines for the Management of Aortic Diseases
-
47m 31sPart 1 | Session 1 ESC Congress 2024 Hot Line Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
27m 27sPart 1 | Session 2 ESC Congress 2024 Hot Line Preview Nicolas M Van Mieghem, Joost Daemen
-
17m 25sPart 2 | Session 1 ESC Day 1 Wrap Up: New Guidelines, HELIOS-B, ABYSS & STOP-or-NOT Mirvat Alasnag, Khaled Al-Shaibi
-
23m 2sPart 2 | Session 2 ESC Day 2 Wrap-Up: NOTION-3, RESHAPE-HF2, TRI.Fr & More Mirvat Alasnag, Khaled Al-Shaibi
-
12m 28sPart 2 | Session 3 Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi Mirvat Alasnag, Khaled Al-Shaibi
-
15m 45sPart 2 | Session 4 Day 4 Wrap-Up: OCCUPI, REC-CAGEFREE I, AEGIS-II & More Mirvat Alasnag, Khaled Al-Shaibi
-
20m 58sPart 3 | Session 1 AβYSS: Beta Blocker Interruption After Uncomplicated MI Harriette Van Spall, Prof. Johanne Silvain
-
20m 14sPart 3 | Session 2 RHEIA: TAVR vs SAVR in Women with Severe AS Helene Eltchaninoff, Harriette Van Spall
-
8m 47sPart 3 | Session 3 OCEANIC-AF: Asundexian Vs Apixaban in Atrial Fibrillation Manesh R Patel, Harriette Van Spall
-
9m 29sPart 3 | Session 4 SWEDEGRAFT: No-touch Vein Graft in CABG Harriette Van Spall, Stefan James
-
17m 28sPart 3 | Session 5 FINEARTS-HF: Finerenone HFmEF & HFpEF Harriette Van Spall, Scott Solomon
-
6m 8sPart 4 | Session 1 Bridging the Gap in Heart Failure Guideline Implementation from a Specialist Nurse Perspective Carys Barton
-
5m 29sPart 4 | Session 2 MATTERHORN: M-TEER vs Surgery in Heart Failure Volker Rudolph, Stephan Baldus
-
5m 46sPart 4 | Session 3 MRAs in Heart Failure Pardeep Jhund
-
4m 24sPart 4 | Session 4 FINE-HEART: Finerenone in HF & CKD Muthiah Vaduganathan
-
8m 18sPart 4 | Session 5 STEEER-AF: Stroke Prevention & Rhythm Control Therapy Dipak Kotecha
-
3m 52sPart 4 | Session 6 NOTION-3: FFR Guided PCI in TAVI Jacob Thomsen Lønborg
-
6m 48sPart 4 | Session 7 EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD Gi-Byoung Nam, Min Soo Cho
-
8m 17sPart 4 | Session 8 SENIOR RITA: Invasive Vs Conservative Strategy for Older Patients with MI Vijay Kunadian
-
3m 51sPart 4 | Session 9 EARTH-STEMI: Complete Vs Culprit-Only Revascularization in Older Patients Gianluca Campo
-
4m 17sPart 4 | Session 10 SCOFF: Fasting vs. Non-Fasting: Impact on Cardiac Catheterization Outcomes David Ferreira
-
4m 17sPart 4 | Session 11 GUARD-AF: Atrial Fibrillation Screening to Reduce Stroke in Elderly Individuals Renato D Lopes
-
2m 31sPart 4 | Session 12 SHAM-PVI: Sham Study of Pulmonary Vein Isolation in Symptomatic Atrial Fibrillation Rick Veasey
-
7m 9sPart 4 | Session 13 POPular PAUSE TAVI: Continuation or interruption of OAC During TAVI Dirk-Jan van Ginkel
Overview
What's hot at the ESC Congress 2024?
Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.
- Watch our View From the Thoraxcenter series for practice-focused reviews of the most anticipated trials from interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen.
- For a deeper dive into key hot line clinical trial data and its applicability, host, Dr Harriette Van Spall meets with principal investigators in her Late-Breaker Discussion series.
- View a condensed summary of the crucial takeaways from each day in our Wrap-Up series led by Dr Mirvat Alasnag.
- Our short, bite-sized Expert Interviews with select faculty will focus on data, take-home messages for practice and the future of their field.
Get ready for a deep dive into the latest cardiology research. Our coverage of the ESC Congress is coming soon.
More from this programme
Part 1
View From the Thoraxcenter: What's Hot at ESC 24?
Part 2
Daily Wrap Ups with Dr Alasnag and Dr Al-Shaibi
Part 3
Hot-line Discussions with Dr Harriette Van Spall
Part 4
Expert Interviews
Part 5
Highlights
Part 6
Guidelines
About the episode
ESC 2024 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.
Trials covered in detail include:
FINE-HEART
HELIOS-B
RESHAPE-HF2
Recorded on-site at ESC Congress 2024, London.
Editors: Jordan Rance and Mirjam Boros.
Videographers: Mike Knight, Dan Brent, Oliver Miles, Tom Green, David-Ben-Harosh.
Support: This is an independent interview produced by Radcliffe Cardiology.
Faculty Biographies
Muthiah Vaduganathan
Co-Director, Center for Cardiometabolic Implementation Science
Dr Muthiah Vaduganathan is a Cardiologist and Clinical Trialist at Brigham and Women’s Hospital and Harvard Medical School, Boston, US. He is co-director of the Center for Cardiometabolic Implementation Science at Brigham and Women’s Hospital. He serves as an Associate Editor of JACC and as US national ambassador to the ESC Heart Failure Association. His research focuses on drug development, clinical trials, and implementation of cardio-kidney-metabolic therapies, and he has authored or co-authored more than 700 peer-reviewed publications. He participates on study leadership of ongoing advanced-phase trials in cardio-kidney-metabolism and heart failure.
Comments